NGEN
NervGen Pharma Corp.
1.90$
+2.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 82.3% | 92.5% | 92.9% | 97.3% | 97.0% | 94.6% | 97.6% | 98.2% | |
| – | 79.9% | 60.7% | 83.9% | 94.6% | 94.0% | 88.1% | 88.6% | 95.1% | |
| – | 79.9% | 60.7% | 83.9% | 94.6% | 94.0% | 88.1% | 89.1% | 95.1% | |
| – | 0.8% | 1.8% | 0.9% | 0.4% | 0.1% | 1.9% | 2.1% | 0.3% | |
| – | 17.7% | 7.5% | 7.1% | 2.6% | 1.8% | 3.9% | 2.4% | 1.8% | |
| – | 18.8% | 13.7% | 11.3% | 6.0% | 43.6% | 115.2% | 86.8% | 85.0% | |
| – | 14.5% | 13.7% | 11.3% | 6.0% | 42.8% | 114.4% | 86.7% | 85.0% | |
| – | – | – | – | – | 0.4% | 0.7% | 0.5% | 0.0% | |
| – | – | – | – | – | 8.5% | 25.1% | – | 20.1% | |
| – | 81.2% | 86.3% | 88.7% | 94.0% | 56.4% | -15.2% | 13.2% | 15.0% | |
| – | -44.2% | -164.6% | -334.4% | -195.8% | -233.6% | -590.5% | -524.3% | -632.3% | |
| – | 881.0% | 372.7% | 480.0% | 217.9% | 222.5% | 447.9% | 345.7% | 311.6% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.